Neuroendocrine Tumor
Symptoms, Doctors, Treatments, Advances & More

Neuroendocrine Tumor Overview

Save information for later
Sign Up

Learn About Neuroendocrine Tumor

What is the definition of Neuroendocrine Tumor?
Neuroendocrine tumors are rare cancers that grow from neuroendocrine cells. Neuroendocrine cells receive signals from the nervous system to release hormones. There are several types of neuroendocrine tumors, although most occur in the lungs, pancreas, adrenal glands, small intestine, appendix, and rectum. Neuroendocrine tumors may also spread to the lymph nodes, liver, or bones.
What are the symptoms of Neuroendocrine Tumor?
Symptoms of a neuroendocrine tumor depend on the tumor’s location and whether it is producing excess hormones. Symptoms of neuroendocrine tumors may include pain, a lump under the skin, fatigue, persistent cough or hoarseness, unexplained weight loss, confusion, anxiety, dizziness, shakiness, elevated blood glucose, low blood glucose, an ulcer, skin flushing, skin rash, increased thirst, nausea and vomiting, diarrhea, and carcinoid syndrome. Carcinoid syndrome is a condition that occurs when a neuroendocrine tumor produces excess hormones. Symptoms of carcinoid syndrome include skin flushing of the head and neck; sweating; shortness of breath; wheezing; rapid heartbeat; heart murmur; high blood pressure; yellowing of the skin and eyes; abdominal cramping; diarrhea; greasy, foul-smelling bowel movements; and swelling of the feet and legs.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Neuroendocrine Tumor?
Treatment for neuroendocrine tumors depends on the type and location, as well as whether the tumor is producing excess hormones. Treatment for endocrine tumors may include surgery; chemotherapy; targeted drug therapy, such as everolimus and sunitinib; immunotherapy, such as interferon alfa-2b; peptide receptor radionuclide therapy; somatostatin analogs, such as octreotide and lanreotide; radiation therapy; radiofrequency ablation; and hepatic artery embolization.
Who are the top Neuroendocrine Tumor Local Doctors?
Elite in Neuroendocrine Tumor
Dr. Daniel M. Halperin
Family Medicine
Elite in Neuroendocrine Tumor
Dr. Daniel M. Halperin
Family Medicine

Emory At Mountain Park - Primary Care Suite 104

4120 Five Forks Trickum Road Southwest, Ste104, 
Lilburn, GA 
770-935-9546
Experience:
21+ years
Languages Spoken:
English
See accepted insurances

Daniel Halperin is a Family Medicine provider practicing medicine in Lilburn, Georgia. He has been practicing medicine for over 21 years. Dr. Halperin is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, and Metastatic Insulinoma. Dr. Halperin is board certified in American Board Of Family Medicine, 2008.

Elite in Neuroendocrine Tumor
Dr. Diane Reidy
Hematology Oncology | Hematology | Oncology
Elite in Neuroendocrine Tumor
Dr. Diane Reidy
Hematology Oncology | Hematology | Oncology
Referral may be required

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
919-681-6900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Diane Reidy is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Reidy is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Neuroendocrine Tumor
Dr. Shishir K. Maithel
Surgical Oncology
Elite in Neuroendocrine Tumor
Dr. Shishir K. Maithel
Surgical Oncology
Referral may be required
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
866-587-4322
Experience:
26+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shishir Maithel is a Surgical Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 26 years. Dr. Maithel is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Disease, Pancreaticoduodenectomy, and Hepatectomy. Dr. Maithel is board certified in American Board Of Surgery - Surgery (Certified).

View All Doctors
What are the latest Neuroendocrine Tumor Clinical Trials?
NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus or Sunitinib or Cabozantinib in Metastatic/Unresectable Gastroenteropancreatic Neuroendocrine Tumours
NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus or Sunitinib or Cabozantinib in Metastatic/Unresectable Gastroenteropancreatic Neuroendocrine Tumours
Enrollment Status: Recruiting
Publish Date: June 18, 2026
Intervention Type: Other, Procedure, Drug
Study Phase: Phase 2

Summary: This phase II trial compares the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual approach of treatment with everolimus, sunitinib, or cabozantinib in patients who have previously received 177Lu-DOTATATE for gastroenteropancreatic neuroendocrine tumor (GEPNET) that has spread from where it first started (primary site) to other places in the body (...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Enrollment Status: Recruiting
Publish Date: June 18, 2026

Summary: This study will investigate how genetic and environmental factors contribute to the development of melanoma, a type of skin cancer, and related conditions. Individuals \>=4 weeks with a personal or family history of melanoma or atypical spitzoid/Spitz tumor may be eligible for this study. Participants will: * Fill out one or two questionnaires about their personal and family medical history. * Pro...

View All Clinical Trials